Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) Forward Dividend Yield %: 0.13% (As of Jul. 09, 2026)


BJSE:920367 Jiangxi Xinganjiang Pharmaceutical Co Ltd BJSE:920367
60 GF Score
Price ¥22.50
GF Value ¥12.11
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Jiangxi Xinganjiang Pharmaceutical Co Forward Dividend Yield %?

Jiangxi Xinganjiang Pharmaceutical Co BJSE:920367 60 Forward Dividend Yield % is 0.13% as of Jul. 09, 2026. GuruFocus rates BJSE:920367 with a GF Score™ of 60/100 and a GF Value™ of ¥12.11 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 507 Drug Manufacturers companies, Jiangxi Xinganjiang Pharmaceutical Co ranks worse than 96.65% on this metric.

As of today (2026-07-09), the Forward Annual Dividend Yield of Jiangxi Xinganjiang Pharmaceutical Co is 0.13%.

As of today (2026-07-09), the Trailing Annual Dividend Yield of Jiangxi Xinganjiang Pharmaceutical Co is 0.13%.

BJSE:920367's Forward Dividend Yield % is ranked worse than
96.65% of 507 companies
in the Drug Manufacturers industry
Industry Median: 2.01 vs BJSE:920367: 0.13

Jiangxi Xinganjiang Pharmaceutical Co's Dividends per Share for the three months ended in Mar. 2026 was ¥0.00.

During the past 12 months, Jiangxi Xinganjiang Pharmaceutical Co's average Dividends Per Share Growth Rate was -60.00% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Jiangxi Xinganjiang Pharmaceutical Co  (BJSE:920367) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Jiangxi Xinganjiang Pharmaceutical Co Forward Dividend Yield % Related Terms


BJSE:920367 vs ZTS, UTHR: Forward Dividend Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangxi Xinganjiang Pharmaceutical Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangxi Xinganjiang Pharmaceutical Co Forward Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangxi Xinganjiang Pharmaceutical Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Jiangxi Xinganjiang Pharmaceutical Co's Forward Dividend Yield % falls into.


BJSE:920367
60GF Score
Jiangxi Xinganjiang Pharmaceutical Co Ltd BJSE:920367
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangxi Xinganjiang Pharmaceutical Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Jiangxi Xinganjiang Pharmaceutical Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
CNY 0.0300002026-06-092026-06-082026-06-09Cash DividendannuallyCNY:CNY 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Jiangxi Xinganjiang Pharmaceutical Co's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.03/22.50
=0.13 %

Current Share Price is ¥22.50.
Jiangxi Xinganjiang Pharmaceutical Co's Dividends per Share for the forward twelve months is calculated as ¥0.03 * 1 = ¥0.03.

Jiangxi Xinganjiang Pharmaceutical Co's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.03/22.50
=0.13 %

Current Share Price is ¥22.50.
Jiangxi Xinganjiang Pharmaceutical Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is ¥0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 0.13% mean?
Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) has a Forward Dividend Yield % of 0.13% as of Jul. 09, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Jiangxi Xinganjiang Pharmaceutical Co and its competitors. According to the industry distribution chart, Jiangxi Xinganjiang Pharmaceutical Co ranks #490 out of 507 companies in the Drug Manufacturers industry, placing it in the top 96.6%.
Is Jiangxi Xinganjiang Pharmaceutical Co's Forward Dividend Yield % too high?
Jiangxi Xinganjiang Pharmaceutical Co's current Forward Dividend Yield % is 0.13%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.01. Jiangxi Xinganjiang Pharmaceutical Co's value of 0.13% is 93.5% below this industry median. Based on the distribution chart, Jiangxi Xinganjiang Pharmaceutical Co ranks #490 out of 507 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Jiangxi Xinganjiang Pharmaceutical Co has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jiangxi Xinganjiang Pharmaceutical Co's Forward Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jiangxi Xinganjiang Pharmaceutical Co ranks #490 out of 507 companies for Forward Dividend Yield %. This places Jiangxi Xinganjiang Pharmaceutical Co in the lower half of its industry. The industry median Forward Dividend Yield % is 2.01. Jiangxi Xinganjiang Pharmaceutical Co's value of 0.13% is 93.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.01, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangxi Xinganjiang Pharmaceutical Co's current Forward Dividend Yield % of 0.13% is 93.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Jiangxi Xinganjiang Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangxi Xinganjiang Pharmaceutical Co's current Forward Dividend Yield % is 0.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangxi Xinganjiang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥12.11, compared to a current price of ¥22.50 — trading 85.8% above its estimated fair value. The current Forward Dividend Yield % is 0.13% and 93.5% below the Drug Manufacturers industry median of 2.01. Jiangxi Xinganjiang Pharmaceutical Co's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367), the current Forward Dividend Yield % is 0.13% as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangxi Xinganjiang Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥22.50 is trading 85.8% above its estimated GF Value™ of ¥12.11. GuruFocus considers Jiangxi Xinganjiang Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for BJSE:920367:

  • Forward Dividend Yield %: 0.13%
  • GF Value™: ¥12.11 vs. price of ¥22.50 (85.8% above fair value)
  • GF Score™: 60/100 with 4 warning signs
  • Industry Position: 93.5% below the Drug Manufacturers median (#490 of 507)

No single metric tells the full story. See the BJSE:920367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jiangxi Xinganjiang Pharmaceutical Co Business Description

Address No. 36 Yunzhang Road, Industrial Park, Jizhou District, Jiangxi Province, Ji'an City, CHN, 343000
Jiangxi Xinganjiang Pharmaceutical Co Ltd conducts research and development, production, and sales of chemical raw materials, chemical preparations, and Chinese patent medicines. The company's raw material medicine products are mainly calcium gluconate, zinc gluconate, ferrous gluconate, and other gluconate series raw material medicines. Its main chemical preparations are vitamin C chewable tablets and compound Yinqiao aminomin capsules, and Phenaminokamin Tablets.
60GF Score

Get the complete analysis for BJSE:920367

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥22.50
Price
¥12.11
GF Value